(Q38420080)

2 September 2017

title

An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitors (English)

1 reference

2 September 2017

0 references

Naveen Dakappagari

1

1 reference

2 September 2017

Laura Neely

2

1 reference

2 September 2017

Shabnam Tangri

3

1 reference

2 September 2017

Karen Lundgren

4

1 reference

2 September 2017

Lori Hipolito

5

1 reference

2 September 2017

Annalee Estrellado

6

1 reference

2 September 2017

Francis Burrows

7

1 reference

2 September 2017

Hong Zhang

8

1 reference

2 September 2017

language of work or name

1 reference

1 February 2010

1 reference

2 September 2017

1 reference

2 September 2017

volume

15

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

31-38

1 reference

BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

Heat shock proteins transfer peptides during antigen processing and CTL priming

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

Role of scavenger receptors in the binding and internalization of heat shock protein 70.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

Extracellular targeting of endoplasmic reticulum chaperone glucose-regulated protein 170 enhances tumor immunity to a poorly immunogenic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

Telomerase as a Target for Cancer Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903261347

10.3109/13547500903261347

21 January 2018

Identifiers

DOI

1 reference

release_663u63y6prch7bfahg6jzbahjy

2 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/663u63y6prch7bfahg6jzbahjy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference